PharmaEssentia Corporation (LUX:261280558)

PharmaEssentia Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,106	6,032	3,383	4,381	2,477	719
Market Cap Growth	55.08%	78.30%	-22.77%	76.88%	244.49%	0.07%
Enterprise Value	4,487	5,449	2,800	4,274	2,462	612
Last Close Price	15.52	18.16	10.21	-	-	-
PE Ratio	47.10	69.04	-	-	-	-
PS Ratio	16.20	21.03	22.44	49.91	118.91	44.34
PB Ratio	6.31	7.45	4.78	11.85	18.37	6.30
P/TBV Ratio	6.36	7.53	4.84	12.08	19.50	6.68
P/FCF Ratio	-	121.51	-	-	-	-
P/OCF Ratio	-	80.38	-	-	-	-
EV/Sales Ratio	13.46	19.00	18.58	48.69	118.21	37.73
EV/EBITDA Ratio	48.22	100.14	-	-	-	-
EV/EBIT Ratio	54.03	106.51	-	-	-	-
EV/FCF Ratio	54.40	109.75	-	-	-	-
Debt / Equity Ratio	0.03	0.04	0.05	0.13	0.13	0.17
Debt / EBITDA Ratio	0.31	0.47	-	-	-	-
Debt / FCF Ratio	0.33	0.57	-	-	-	-
Asset Turnover	0.38	0.33	0.24	0.27	0.11	0.13
Inventory Turnover	0.94	0.86	0.48	0.83	0.60	1.15
Quick Ratio	8.48	9.34	9.86	4.37	2.80	3.37
Current Ratio	9.07	9.94	10.64	5.24	3.49	3.82
Return on Equity (ROE)	14.56%	11.54%	-3.46%	-16.77%	-68.81%	-63.10%
Return on Assets (ROA)	5.86%	3.72%	-5.61%	-11.77%	-30.08%	-25.26%
Return on Capital (ROIC)	6.34%	4.05%	-6.16%	-13.71%	-37.72%	-29.60%
Return on Capital Employed (ROCE)	9.40%	6.10%	-	-	-	-
Earnings Yield	2.12%	1.45%	-0.54%	-0.96%	-3.60%	-7.88%
FCF Yield	1.62%	0.82%	-1.74%	-1.26%	-3.24%	-6.22%
Dividend Yield	-	0.18%	-	-	-	-
Buyback Yield / Dilution	-1.10%	-3.59%	-13.47%	-9.24%	-7.39%	-10.55%
Total Shareholder Return	-	-3.41%	-13.47%	-9.24%	-7.39%	-10.55%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.